Evaluation of the effect of Dual Follicle Stimulating Hormone(FSH)/Human Chorionic Gonadotropin hormone(HCG) triggering on the success rate ofIntrauterine insemination (IUI) in couples diagnosed with unexplained infertility.

Evaluation of the effect of Dual FSH/HCG triggering on the success rate of IUI in couples diagnosed with unexplained infertilityEvaluation of the effect of Dual Follicle Stimulating Hormone(FSH)/Human Chorionic Gonadotropin hormone(HCG) triggering on the success rate ofIntrauterine insemination (IUI) in couples diagnosed with unexplained infertility.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20220702055335N2

Enrollment

Registered

2022-09-06

Start date

2022-08-27

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Female infertility. Female infertility, unspecified

Interventions

Intervention 1: Intervention group: after checking the state of the ovaries and ensuring the presence of at least one mature follicle larger than 18 mm (between one and five follicles) and a suitable

Eligibility

Sex/Gender

Female

Age

20 Years to 38 Years

Inclusion criteria

Inclusion criteria: Having an informed consent to participate in the study Unexplained infertility diagnosis The health of the uterus structure Normal pap smear test Normal sperm analysis Women between 20 and 38 years old

Exclusion criteria

Exclusion criteria: Moderate to severe endometriosis Hyper prolactinemia Hyperthyroidism Hypothyroidism Ovarian Cysts Kidney and liver failure Secondary infertility

Design outcomes

Primary

Measure	Time frame
Clinical pregnancy rate. Timepoint: 28 days after transfer. Method of measurement: Vaginal sonography.	—

Secondary

Measure	Time frame
Chemical pregnancy rate. Timepoint: 14 days after transfer. Method of measurement: BhCG test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Parvin Hakimi

Tabriz University of Medical Sciences

lahroudin@gmail.com+98 35519161

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026